General Information of Drug Metabolite (DM) (ID: DM017825) |
DM Name |
TNP-470 Metabolite MIV
|
Structure |
|
3D MOL is unavailable
|
2D MOL is unavailable
|
|
|
|
|
|
|
|
Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
DME(s) Producing This DM through Metabolism |
DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
Amidase (AMS)
|
DMEN243
|
| Unclear - Unclear |
TNP-470
|
[1] |
Esterases (ES)
|
DMEN229
|
| Unclear - Unclear |
TNP-470
|
[1] |
|
|
|
|
|
|
|
DME(s) Metabolizing This DM |
DME Name |
DME ID |
Product |
Reaction |
Related Drug |
REF |
Epoxide hydrolase 1 (EPHX1)
|
DME0623
|
| Unclear - Unclear |
TNP-470
|
[2] |
|
|
|
|
|
|
|
|
|
|
|
|
|
Full List of Drug(s) That Produce This DM By Metabolism |
TNP-470 |
DR2933
|
Discontinued in Phase 2 |
Solid tumour/cancer |
|
References |
1 |
Pharmacokinetics and metabolism of O-(chloroacetyl-carbamoyl) fumagillol (TNP-470, AGM-1470) in rhesus monkeys
|
2 |
Phase I dose escalation pharmacokinetics of O-(chloroacetylcarbamoyl) fumagillol (TNP-470) and its metabolites in AIDS patients with Kaposi's sarcoma
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.